Cite
MLA Citation
Manali Kamdar et al.. “Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.” Lancet, vol. 399, no. 10343, 2022, pp. 2294–2308. http://access.bl.uk/ark:/81055/vdc_100157244160.0x00004c